HCA Congressional Stock Trades & Insider Buying (2026)

HCA insider buying and selling over the past year

Insiders at HCA Healthcare, Inc. only sold stock in the open market over the past year: 6 Form 4 sales totaling $31.12M, against no open-market purchases.

None of the 6 sales were flagged as Rule 10b5-1 plan trades, meaning each one was a discretionary decision at the time of filing. Activity clustered in 2026-02 (5 trades) and 2025-11 (1 trades); the latest filing in this window is dated 2026-02-18. The average open-market sale price was $502.15; the last close of $458.84 is 8.6% below that level, so sellers exited above the current price. The single largest trade was a sale of 42,877 shares worth $21.48M on 2026-02-03. Since the most recent filing the stock has moved -14.2%, from $535.02.

Where HCA trades relative to its one-year range

HCA Healthcare, Inc. closed at $458.84 on 2026-10-16, inside a one-year range of $361.32 to $545.13. That puts the stock in the middle of its range, at 53.1% of the distance from low to high. Over one year the share price moved +9.4%, and over roughly three months +23.6%. Average daily volume over the last month was about 1,346,168 shares.

Across 27 companies in the same SEC industry group (SIC 80) with a full year of prices in Gemral Edge, the median one-year return was +18.9%. HCA is behind that median and beat 33% of that peer group on this measure.

Members of Congress who traded HCA

STOCK Act disclosures show 34 trades in HCA by 9 members of Congress over five years (14 purchases, 20 sales), most recently on 2026-09-04. The most active traders were Ro Khanna (D-CA), 20 trades; Jared Moskowitz (D-FL), 4 trades; Lisa C. McClain (R-MI), 3 trades; Val T. Hoyle (D-OR), 2 trades; Alan Armstrong (R-OK), 1 trade.

By party the trades split 29 by Democrats, 5 by Republicans; by chamber, 33 from the House, 1 from the Senate.

Compare HCA with indexed peers from the same industry group

These peers have full Gemral Edge dossiers and the closest one-year price move to HCA:

• LH one-year return +12.1%
• DGX one-year return +25.8%

Sources and method

Every figure above is computed from public filings stored in Gemral Edge, not estimated. Insider figures count only open-market purchases and sales reported on SEC Form 4; option exercises, grants and gifts are excluded because they do not reflect a decision to buy or sell at market prices.

• SEC EDGAR Form 4 (edge_insider_trades, codes P/S open-market only) — as of 2026-02-18
• edge_prices_eod (end-of-day close) — as of 2026-10-16
• House PTR / Senate eFD disclosures (edge_congress_trades) — as of 2026-09-04

HCA data questions

Are HCA insiders buying or selling stock?

Insiders at HCA Healthcare, Inc. only sold stock in the open market over the past year: 6 Form 4 sales totaling $31.12M, against no open-market purchases.

What is the one-year price range for HCA?

Based on end-of-day closes through 2026-10-16, HCA traded between $361.32 and $545.13, last closing at $458.84.

Has any member of Congress traded HCA stock?

Yes. 9 members disclosed 34 trades in HCA over five years; the most recent disclosed trade date is 2026-09-04.